Search

everythinglearnresearchcommunity

for

Search:↓

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

A woman with lupus developed rare skin growths that went away on their own.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Tofacitinib taken by mouth helps treat hair loss in children.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

3D imaging effectively tracks skin changes in vitiligo treatment.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.